Pa gynlluniau sydd gan Lywodraeth Cymru i sicrhau bod brechlyn Arexvy ar gael yn rhwydd yng Nghymru i drin feirws syncytiol anadlol?
Wedi'i ateb gan Y Gweinidog Iechyd a Gwasanaethau Cymdeithasol | Wedi'i ateb ar 23/01/2024
Arexvy is an approved vaccine to protect against Respiratory Syncytial Virus (RSV) that may be used to protect older adults. There are also other licensed products which could be used to protect against RSV.
The Joint Committee on Vaccination and Immunisation has recommended establishing an RSV vaccination programme, if vaccines can be procured at a cost-effective price. Such a programme could provide protection for both older adults and infants.
The Welsh Government and NHS Wales are now working with the other UK Nations to explore options for standing up an RSV vaccination programme.